Shilpa Medicare shares rise 6% on CEP approvals from EDQM
The first CEP was, received on November 18, was for Octreotide, a synthetic peptide manufactured via solid-phase synthesis.
cnbctv1827m
Shilpa Medicare rallies as subsidiary gets European regulator’s nod for blood pressure drug
Shilpa Medicare Ltd shares rose over 6% in early trade on Tuesday, November 19, after its subsidiary secured a Certificate of ...